A2 Biotherapeutics is an early-stage biotechnology company that develops medicines for serious illnesses.
A2 Biotherapeutics is an early-stage biotechnology company located in Southern California that develops novel medicines for serious illnesses. They utilize an advanced targeting technology platform to increase the effectiveness of the body’s natural immune defenses.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 19, 2022 | Series B | $62M | — | — | — | Detail |
Oct 6, 2020 | Series B | $71.50M | 8 | — | — | Detail |
Nov 5, 2019 | Series A | $57M | 4 | — | — | Detail |
Jan 1, 2019 | Seed | — | 1 | — | — | Detail |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Oct 19, 2020
Genius Teacher
|
Angel | $2M | EdTech | — |
Sep 4, 2019
Atomberg Technology
|
Series A | $10M | Consumer Electronics | — |
Nov 9, 2015
Zilingo
|
Seed | $1.88M | E-Commerce | — |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Casdin Capital | — | Series B |
Euclidean Capital | — | Series B |
Hartford HealthCare Endowment | — | Series B |
Nextech Invest | — | Series B |
Samsara BioCapital | — | Series B |
The Column Group | — | Series B |
UC Investments | — | Series B |
Vida Ventures | — | Series B |